The company is demonstrably boosted this course of an novel therapy for amyloid heart disease, leveraging the investigational drug. Initial patient data reveals significant benefits for patients diagnosed with the https://attruby651559.fitnell.com/83254750/bridgebio-improves-attr-cm-management-using-the-therapy